Mesoblast (MEOBF) Net Cash Flow (2014 - 2023)

Mesoblast has disclosed Net Cash Flow across 10 years of filings, most recently posting $149.0 million for Q2 2023.

• In Q2 2023, Net Cash Flow rose 1022.41% year-over-year to $149.0 million; the TTM figure through Jun 2023 stood at $137.6 million (up 448.42% YoY), while the FY2026 annual figure was $27.5 million, down 86.08% from the prior year.
• Net Cash Flow came in at $149.0 million for Q2 2023 at Mesoblast, up from -$80.2 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $149.0 million in Q2 2023 to a low of -$80.2 million in Q1 2023.
• Average Net Cash Flow over 5 years is $7.6 million, with a median of -$11.3 million recorded in 2019.
• The largest YoY upside for Net Cash Flow was 1022.41% in 2023 against a maximum downside of 343.42% in 2023.
• Over 5 years, Net Cash Flow stood at $30.6 million in 2019, then sank by 203.72% to -$31.7 million in 2020, then surged by 33.25% to -$21.2 million in 2021, then soared by 168.02% to $14.4 million in 2022, then soared by 934.38% to $149.0 million in 2023.
• Per Business Quant data, the three most recent Net Cash Flow figures were $149.0 million in Q2 2023, -$80.2 million in Q1 2023, and $14.4 million in Q4 2022.